Specialty Pharmacists Reduce Treatment Interruptions in Inflammatory Bowel Disease | ASHP Midyear 2025ByAshley Gallagher,Shubha Bhat, PharmD, MSDecember 7th 2025Misinformation, limited understanding of biosimilars, and inconsistent insurance policies only add to the confusion.